Q² Solutions Pediatric Drug Development Solutions

More pharmaceutical clinical trial studies are enrolling pediatric subjects because they can respond to drugs differently than adults do. New drugs which are intended for use in a pediatric population must be tested and properly evaluated for use in pediatric patients. However, obtaining quality samples with enough volume for testing from very young pediatric subjects can be difficult, and tests are often canceled if samples are received in a clinical laboratory are too low a volume. We recognize the need to reduce the blood volume required in this special population, and we have established policies and procedures specifically tailored for pediatric sample collection and handling.

Our testing assures the best chance for reliable results on very low volume samples. Read in our brochure about our capabilities including established precise low volume blood sample requirements, recommendations for minimum blood volumes by age group, and specialized collection supplies.